REGN vs XBPEW · P/E 14, rev $4.29B vs rev $191.3M
Regeneron Pharmaceuticals Inc (REGN) versus XBP Europe Holdings Inc (XBPEW) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
XBP Europe Holdings Inc (XBPEW) is a software - infrastructure company listed on US.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported XBPEW revenue for 2026-06-30 was $191.3M. Net income was -$16.7M. Revenue was down 3.0% from 2026-03-31 to 2026-06-30. XBPEW currently screens at market cap $0.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. XBPEW currently screens at market cap $0.
Not investment advice. Open the REGN and XBPEW stock pages for the full models.
Not investment advice.